Here, we used GEPIA to analyze differentially expressed genes found in OSCC, and we found LINC01296 is highly expressed in several types of tumors (Figure 1(a)) and significantly increased in head and neck squamous cell carcinoma (Figure 1(b)), and survival curve shows that patients with high expression of LINC01296 have a lower survival rate in the first 150 months (Figure 1(c)). Here, DUXAP9 is linked to head and neck squamous cell carcinoma.